Cytotoxicity and Anti-inflammatory Properties of Apigenin-Derived Isolaxifolin

被引:15
作者
Chen, Yongsheng [1 ,2 ]
Chen, Wan-Na [4 ]
Hu, Nan [1 ]
Banwell, Martin G. [1 ,3 ]
Ma, Chenxi [3 ]
Gardiner, Michael G. [3 ]
Lan, Ping [1 ,4 ]
机构
[1] Jinan Univ, Inst Adv & Appl Chem Synth, Guangzhou 510632, Guangdong, Peoples R China
[2] Jinan Univ, Dept Food Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China
[3] Australian Natl Univ, Inst Adv Studies, Res Sch Chem, Canberra, ACT 2601, Australia
[4] Jinan Univ, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China
来源
JOURNAL OF NATURAL PRODUCTS | 2019年 / 82卷 / 09期
关键词
CELL-CYCLE; FLAVONOIDS; APOPTOSIS; INHIBITION; INDUCTION; CARCINOMA; SUPPRESSES; ACTIVATION; PREVENTION; LUTEOLIN;
D O I
10.1021/acs.jnatprod.9b00113
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The rare flavonoid isolaxifolin, a potent insecticide, has been touted as a potential grain-protecting agent. In order to assess any impact of this natural product on human health and to explore its various other biological properties, we have established a semisynthesis from the simpler but structurally related and more abundant natural product apigenin. The five-step reaction sequence has provided, for the first time, sufficient material for an in-depth evaluation of the cytotoxic properties of the title natural product. The impact of isolaxifolin on certain pro-inflammatory cytokines in murine macrophage RAW 264.7 cells has also been examined. Such studies have revealed that isolaxifolin displays no toxic effects toward normal cells while displaying greater cytotoxicities against certain cancer cell lines than its synthetic precursor apigenin. Furthermore, unlike apigenin, isolaxifolin only reduced NO, TNF-alpha, and IL-6 secretions in LPS-induced RAW 264.7 cells in a rather modest and dose-independent manner.
引用
收藏
页码:2451 / 2459
页数:9
相关论文
共 52 条
[1]   Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe [J].
Aggarwal, Bharat B. ;
Vijayalekshmi, R. V. ;
Sung, Bokyung .
CLINICAL CANCER RESEARCH, 2009, 15 (02) :425-430
[2]  
Agilent Technologies, CRYSALIS PRO VERS 1
[3]   Synthesis of lupiwighteone via a para-Claisen-Cope rearrangement [J].
Al-Maharik, N ;
Botting, NP .
TETRAHEDRON, 2003, 59 (23) :4177-4181
[4]   Health functionality of apigenin: A review [J].
Ali, Fahad ;
Rahul ;
Naz, Falaq ;
Jyoti, Smita ;
Siddique, Yasir Hasan .
INTERNATIONAL JOURNAL OF FOOD PROPERTIES, 2017, 20 (06) :1197-1238
[5]   Fractionation and Characterization of Lycopene-Oxidation Products by LC-MS/MS (ESI)+: Elucidation of the Chemopreventative Potency of Oxidized Lycopene in Breast-Cancer Cell Lines [J].
Arathi, Bangalore Prabhashankar ;
Sowmya, Poorigali Raghavendra-Rao ;
Kuriakose, Gini Chempakathinal ;
Shilpa, Shivaprasad ;
Shwetha, Hulikere Jagdish ;
Kumar, Sharath ;
Raju, Marisiddaiah ;
Baskaran, Vallikannan ;
Lakshminarayana, Rangaswamy .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (43) :11362-11371
[6]   Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats [J].
Bhattacharya, Sanchari ;
Mondal, Laboni ;
Mukherjee, Biswajit ;
Dutta, Lopamudra ;
Ehsan, Iman ;
Debnath, Mita C. ;
Gaonkar, Raghuvir H. ;
Pal, Murari M. ;
Majumdar, Subrata .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 14 (06) :1905-1917
[7]   Dietary agents in cancer prevention: flavonoids and isoflavonoids [J].
Birt, DF ;
Hendrich, S ;
Wang, WQ .
PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) :157-177
[8]   Targeting the cell cycle for cancer therapy [J].
Carnero, A .
BRITISH JOURNAL OF CANCER, 2002, 87 (02) :129-133
[9]   Phytochemical Profiles and Antioxidant Activity of Different Varieties of Adinandra Tea (Adinandra Jack) [J].
Chen, Yongsheng ;
Chen, Gu ;
Fu, Xiong ;
Liu, Rui-Hai .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2015, 63 (01) :169-176
[10]   Two new flavonoids from Derris laxiflora Benth [J].
Chien, Shih-Chang ;
Chen, Chien-Chih ;
Wang, Sheng-Yang ;
Wu, Jyh-Horng ;
Shih, Chun-Ching ;
Chao, Louis Kuoping ;
Chao, Che-Yi ;
Chiu, His-Lin ;
Kuo, Yueh-Hsiung .
PHYTOCHEMISTRY LETTERS, 2017, 21 :29-31